Smoking Reduction Clinical Trial
Official title:
Cathelicidin LL-37 Levels in the Gingival Crevicular Fluid and the Saliva of Smokers and Non-smokers With Stage III,IV Periodontitis :An Observational Study
Periodontitis is considered an inflammatory disease that results in the disruption of oral hemeostasis and is associated with the presence of dental plaque influenced by genetic and environmental factors. It is well-establised that smokers have an increased severity of periodontal disease,a higher prevalance of tooth loss and total edentulism.
Antimicrobial peptides (AMPs) are soluble molecules participating in the innate immunity of mucosal surfaces against pathogens. Dysregulated expression of AMPs has been considered a possible causal mechanistic link in the microbial dysbiosis associated with periodontal disease and some risk factors, including tobacco smoking, diabetes mellitus, and obesity.Antimicrobial peptides as a part of innate immunity are important molecules that provide a balance between disease and health. Moreover, they are considered to be an important intermediate step in initiating an initial immune response against the microbial side of the gingival epithelium and in the transition to acquired immunity. Cathelicidins, in particular - which play an important role in regulating the immunological response of oral tissues, are a group of peptides released from neutrophil granules and they are present only in humans in the form of LL-37. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04133064 -
Assessment of the Pivot Breath Sensor: Single-Arm Cohort Study
|
N/A | |
Completed |
NCT04808609 -
Smoking Cessation Pilot for People Living With HIV (PLWH)
|
N/A | |
Recruiting |
NCT05594199 -
Feasibility of a Virtual Smoking Cessation Program
|
N/A | |
Enrolling by invitation |
NCT05554120 -
The Next Step in Smoking Prevention: the Reduction of Tobacco Retail Outlets, a Comprehensive Policy Evaluation
|
||
Recruiting |
NCT04620915 -
Construal Level as a Novel Pathway for Affect Regulation and Cancer Control
|
N/A | |
Recruiting |
NCT05694754 -
Transcranial Magnetic Stimulation Theta Burst (TMS), Depression and Smoking.
|
N/A | |
Active, not recruiting |
NCT04982952 -
Contingency Management for Smoking Cessation
|
N/A | |
Recruiting |
NCT05555069 -
The Impact of Menthol Flavoring on Switching in Adult Menthol Smokers
|
N/A | |
Completed |
NCT04572126 -
Feasibility and Efficacy of a Brief Mindfulness-Based Intervention SMOKING INTERVENTION VIA THE INTERNET
|
N/A | |
Recruiting |
NCT06311162 -
Early Life Intervention in Pediatrics Supported by E-health - SMOKE
|
N/A | |
Completed |
NCT03612804 -
Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment
|
N/A | |
Recruiting |
NCT05660525 -
Leveraging Community Pharmacists to Optimize Smoking Cessation Services for Rural Smokers in Appalachia
|
N/A | |
Completed |
NCT04857515 -
Clinical Learning Study for a Mobile Smoking Cessation Program
|
||
Not yet recruiting |
NCT04891939 -
Development and Assessment of a Teacher-led Intervention in Preventing Tobacco Use Among the Youth in Ghana
|
N/A | |
Not yet recruiting |
NCT06458205 -
Impact of Multi-Component Interventions on High-Risk COPD Smokers
|
N/A | |
Recruiting |
NCT05703672 -
Switching to E-cigarettes in African-American Smokers
|
Phase 3 | |
Completed |
NCT03083353 -
Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation
|
Early Phase 1 | |
Completed |
NCT04749017 -
The Potential Effect of Avena Sativa L. on Wellness/Wellbeing During Smoking Reduction/Cessation Experience
|
N/A | |
Recruiting |
NCT05016505 -
Supporting Smoke-Free Policy Compliance in Public Housing
|
N/A | |
Completed |
NCT04787978 -
Creating Healthier Communities Through Meaningful Partnerships: A Model From the National African American Male Wellness Initiative - OSU Partnership
|
N/A |